Spectrumedics
Latest round
- Series B
Last raised
- Aug 2024
Total raised
- $15M
Investors
- 8
About Spectrumedics
Founded in 2019 and based in Shanghai, China, Spectrumedics operates as a therapeutic device developer dedicated to providing minimally invasive cardiac and vascular interventional therapy solutions. It has R&D Centres in Shanghai and Singapore. The founder of the company, Huiqun Peng graduated from Nanyang Technological University. The co-founder of the company, Al Ray Tabiliran has worked in Creganna-Tactx Medical and TriReme Medical, Inc. The company mainly provides active cardiac and vascular intervention solutions. It provides coronary calcification solutions and peripheral calcification solutions. The coronary calcification solution is Sonico-CX® Shock Wave Balloon, which used for pretreatment and balloon dilatation of calcified lesions in coronary arteries in adult patients. The peripheral calcification solution is Sonico-PX® Shock Wave Balloon, which used for pretreatment and balloon dilatation of calcified lesions in peripheral arteries of adult patients. Spectrumedics also provides intravascular shock wave therapy equipment. The company generates revenue by providing Sonico-CX® Shock Wave Balloon, Sonico-PX® Shock Wave Balloon, and intravascular shock wave therapy equipment.
Who invested in Spectrumedics
8 investors across 3 rounds
See all investors in Spectrumedics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Spectrumedics
Who invested in Spectrumedics?
Spectrumedics has 8 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Spectrumedics raised?
Spectrumedics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Spectrumedics last raise money?
Spectrumedics's most recent round on record is a Series B, in Aug 2024.
What does Spectrumedics do?
Founded in 2019 and based in Shanghai, China, Spectrumedics operates as a therapeutic device developer dedicated to providing minimally invasive cardiac and vascular interventional therapy solutions.
Where is Spectrumedics headquartered?
Spectrumedics is headquartered in Shanghai, China.
Which VCs invest in companies like Spectrumedics?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back medical devices & equipment companies at Spectrumedics's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series B
Raising like Spectrumedics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.